• Rivkin Center Awards $1.18 Million in Ovarian Cancer Research Grants
  • Personalized Vaccine for Advanced Ovarian Cancer Offers Promising Results in Pilot Study
  • Approved Blood Cancer Inhibitors May Be Effective Therapy for Ovarian Tumors, Study Finds
  • Bright Pink Creates Online Courses on Preventing Ovarian and Breast Cancer
  • First Patient Treated in Test of OLT38, a Dye to Detect Ovarian Cancer Tissue During Surgery
  • Zejula-Keytruda Combo Shows Promise in Certain Ovarian Cancer Patients in Clinical Trial
  • Bedside Chart Improves Cancer Patients’ Pain Management, Study Shows
  • FATE-NK100 Shows Signs of Tumor Reduction in First Ovarian Cancer Patients in Phase 1 Trial
  • Personalized Immunotherapy May Be Effective Ovarian Cancer Treatment, Study Finds
  • EU’s CHMP Supports Rubraca’s Approval for Advanced, Recurrent Ovarian Cancer
  • Phase 1 Trial Finds TPIV200 Is Safe, Delays Recurrence in Ovarian, Breast Cancer
  • Cotinga Looks to Expand COTI-2 Trial to Include Other Therapy Combos